Scarica l'app Stockscreener
3.18
2.58%
0.08
Precedente Chiudi:
$3.10
Aprire:
$3.09
Volume 24 ore:
101.39K
Relative Volume:
1.96
Capitalizzazione di mercato:
$43.97M
Reddito:
-
Utile/perdita netta:
$-11.61M
Rapporto P/E:
-2.4564
EPS:
-1.2946
Flusso di cassa netto:
$-11.82M
1 W Prestazione:
+7.25%
1M Prestazione:
-7.69%
6M Prestazione:
-8.49%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.09
$3.325
Intervallo di 1 settimana:
$2.85
$3.37
Portata 52W:
$1.75
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
Nome
Grace Therapeutics Inc
Settore
Industria
Telefono
609-322-1602
Indirizzo
103 CARNEGIE CENTER, PRINCETON
Confronta GRCE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.18 | 44.53M | 0 | -11.61M | -11.82M | -1.2946 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.67 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.70 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.26 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
638.23 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.03 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2020-09-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Iniziato | B. Riley FBR | Buy |
| 2019-07-18 | Iniziato | Oppenheimer | Outperform |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
Grace Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025 - MarketScreener
Grace Therapeutics, Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q1 2026 Financial Results and Business Update - TradingView
Grace Therapeutics Seeks FDA Approval for First aSAH Treatment Innovation in 40 Years, Reports Q1 Results - Stock Titan
Grace Therapeutics Inc. stock chart pattern explainedSecure Asset Flow and Trend Pattern Analysis - Newser
Applying sector rotation models to Grace Therapeutics Inc.Triple Digit Gain Opportunity Watchlist - Newser
How to track smart money flows in Grace Therapeutics Inc.Strategy Builder for Growth Focused Traders - Newser
Is Grace Therapeutics Inc. meeting your algorithmic filter criteriaSmart Swing Picks with Confirmed Signals - Newser
Visual trend scoring systems applied to Grace Therapeutics Inc.Market Sentiment Tracker with Smart Alerts - Newser
Backtesting results for Grace Therapeutics Inc. trading strategiesWatchlist Generator for Smart Money Signals - Newser
Published on: 2025-08-10 22:04:39 - Newser
Candlestick signals on Grace Therapeutics Inc. stock todayBuy Strategy with Smart Exit Timing - Newser
How Grace Therapeutics Inc. stock performs during market volatilityGrowth Projection Summary for Long-Term Investors - Newser
Will Grace Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsSmart Risk Entry Zone Technical Analysis - Newser
Statistical indicators supporting Grace Therapeutics Inc.’s strengthHigh Return Strategy with Low Risk - Newser
Why Grace Therapeutics Inc. stock attracts strong analyst attentionMulti-Bagger Detection with Trend Tools - Newser
Leading vs lagging indicators on Grace Therapeutics Inc. performance2-Day Signal Watch with Forecast Outcome - Newser
Reversal indicators forming on Grace Therapeutics Inc. stockTrade Alert System with Volume Analysis - Newser
Grace Therapeutics Inc.’s volatility index tracking explainedSecure Asset Flow and Trend Pattern Analysis - Newser
Using Bollinger Bands to evaluate Grace Therapeutics Inc.Buy and Exit Strategy Based on Momentum - Newser
Will Grace Therapeutics Inc. price bounce be sustainableWeekly Return Plan for Conservative Traders - Newser
Grace Therapeutics, Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Does Grace Therapeutics Inc. fit your quant trading modelPredictive System for Long-Term Stock Forecast - Newser
Sector Leaders Rotate Capital Into Grace Therapeutics Inc.High Win Rate Trading Opportunities Detected - metal.it
When is Grace Therapeutics Inc. stock expected to show significant growthAchieve rapid financial growth with smart picks - Jammu Links News
How strong is Grace Therapeutics Inc. company’s balance sheetCapitalize on market trends with confidence - Jammu Links News
What are Grace Therapeutics Inc. company’s key revenue driversFree Stock Market Beginners Guide - Jammu Links News
What institutional investors are buying Grace Therapeutics Inc. stockUnmatched profit potential - Jammu Links News
Why is Grace Therapeutics Inc. stock attracting strong analyst attentionPhenomenal trading returns - Jammu Links News
Is Grace Therapeutics Inc. stock overvalued or undervaluedBuild a winning investment strategy - Jammu Links News
What catalysts could drive Grace Therapeutics Inc. stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
What is Grace Therapeutics Inc. company’s growth strategyFree Wealth Planning Blueprint - Jammu Links News
How volatile is Grace Therapeutics Inc. stock compared to the marketAchieve superior returns with professional insights - Jammu Links News
Grace Therapeutics Inc Azioni (GRCE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
3.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):